Aptera Motors prices $6M registered direct offering with concurrent warrant private placement
On November 10, 2026, Aptera Motors, a solar electric vehicle developer, agreed with institutional investors to sell about 3.43 million Class B shares at $1.75 each in a registered direct offering. A concurrent private placement adds warrants for the same number of shares at a $2.05 exercise price, exercisable only after stockholder approval. Gross proceeds of about $6 million are earmarked for vehicle validation, manufacturing readiness and production planning, with closing expected around November 11, 2026. The company is not a pharma business, so the item is of limited relevance to life-sciences readers.
Company's press release (SEC filing): Aptera Motors Corp ↗
Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.
IndustryCompany releaseIM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M
IndustryCompany releaseHelus Pharma, formerly Cybin, reports $150.9M six-month net loss as share compensation rises
IndustryCompany releaseIM Cannabis sells German arm to CEO-controlled Slil, refocusing on Israel
IndustryCompany releaseDataMEDS AI Q3 revenue up 50% to $2.7M on GLP-1 dispensing
IndustryCompany releaseXenetic reports Q3 loss, advances all-stock Santersus deal and doses first DNase I CAR-T patient
IndustryCompany release